Retroviruses integrate a DNA copy of their genome into host DNA as an obligatory step in their replication cycle. Recent work focusses on the structure and function of HIV integrase, the viral enzyme that catalyzes insertion of the viral DNA into the host chromosome. The N- terminal domain of this enzyme binds zinc with a stoichiometry of one zinc per monomer. In the absence of zinc, the isolated N-terminal is disordered, but in the presence of zinc it adopts a structure with a high alpha helical content as judged by circular dichroism. The solution structure of this domain is currently being studied in collaboration with the Gronenborn and Clore laboratories in LCP/NIDDK. The structure of the catalytic core domain and the C-terminal DNA binding domain of HIV integrase have previously been determined by X- ray crystallography and NMR; efforts to obtain diffracting crystals of the intact protein are in progress. Other aspects of retroviral DNA integration are studied with Moloney murine leukemia virus as a model system. The viral DNA made by reverse transcription exists as part of a high molecular weight nucleoprotein complex derived from the core of the infecting virion. The viral DNA within this complex is protected from self-destructive integration into itself (autointegration). A cellular protein is responsible for conferring the protection. This protein has been purified from NIH3T3 cells using in vitro reconstitution of the autointegration barrier as an assay.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK036108-09
Application #
2573112
Study Section
Special Emphasis Panel (LMB)
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Li, Min; Craigie, Robert (2006) Virology: HIV goes nuclear. Nature 441:581-2
Li, Min; Mizuuchi, Michiyo; Burke Jr, Terrence R et al. (2006) Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J 25:1295-304
Williams, Kerry L; Zhang, Yijun; Shkriabai, Nick et al. (2005) Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor. J Biol Chem 280:7949-55
Li, Min; Craigie, Robert (2005) Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration. J Biol Chem 280:29334-9
Bradley, Christina Marchetti; Ronning, Donald R; Ghirlando, Rodolfo et al. (2005) Structural basis for DNA bridging by barrier-to-autointegration factor. Nat Struct Mol Biol 12:935-6
Bradley, Christina Marchetti; Craigie, Robert (2005) Seeing is believing: structure of the catalytic domain of HIV-1 integrase in complex with human LEDGF/p75. Proc Natl Acad Sci U S A 102:17543-4
Shkriabai, Nick; Patil, Sachindra S; Hess, Sonja et al. (2004) Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry. Proc Natl Acad Sci U S A 101:6894-9
Suzuki, Youichi; Yang, Hongfei; Craigie, Robert (2004) LAP2alpha and BAF collaborate to organize the Moloney murine leukemia virus preintegration complex. EMBO J 23:4670-8
Bradley, Christina; Craigie, Robert (2003) MoMLV reverse transcriptase regulates its own expression. Cell 115:250-1
Segura-Totten, Miriam; Kowalski, Amy K; Craigie, Robert et al. (2002) Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly. J Cell Biol 158:475-85

Showing the most recent 10 out of 15 publications